Trial · NCT03305809
Results by group159
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 159
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Continuity of Attention (CoA) Composite Score of the Cognitive Drug Research Computerized Cognition Battery (CDR-CCB) | Placebo | 1.04 | 95% Confidence Interval -0.339 to 2.373 | Units on a scale | |
| Change From Baseline in the Continuity of Attention (CoA) Composite Score of the Cognitive Drug Research Computerized Cognition Battery (CDR-CCB) | 10 mg LY3154207 | 0.15 | 95% Confidence Interval -1.206 to 1.496 | Units on a scale | |
| Change From Baseline in the Continuity of Attention (CoA) Composite Score of the Cognitive Drug Research Computerized Cognition Battery (CDR-CCB) | 30 mg LY3154207 | 0.96 | 95% Confidence Interval -0.448 to 2.362 | Units on a scale | |
| Change From Baseline in the Continuity of Attention (CoA) Composite Score of the Cognitive Drug Research Computerized Cognition Battery (CDR-CCB) | 75 mg LY3154207 | 0.26 | 95% Confidence Interval -1.310 to 1.801 | Units on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study-Clinician Global Impression of Change (ADCS-CGIC) Score | Placebo | 4.0 | Standard Error 0.13 | Score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study-Clinician Global Impression of Change (ADCS-CGIC) Score | 10 mg LY3154207 | 3.8 | Standard Error 0.12 | Score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study-Clinician Global Impression of Change (ADCS-CGIC) Score | 30 mg LY3154207 | 3.3 | Standard Error 0.13 | Score on a scale | |
| Change From Baseline on the Alzheimer's Disease Cooperative Study-Clinician Global Impression of Change (ADCS-CGIC) Score | 75 mg LY3154207 | 3.1 | Standard Error 0.15 | Score on a scale | |
| Change From Baseline on the CDR-CCB Power of Attention (PoA) Composite Score | Placebo | 64.14 | Standard Error 48.681 | Units on a scale | |
| Change From Baseline on the CDR-CCB Power of Attention (PoA) Composite Score | 10 mg LY3154207 | -6.57 | Standard Error 48.396 | Units on a scale | |
| Change From Baseline on the CDR-CCB Power of Attention (PoA) Composite Score | 30 mg LY3154207 | -42.88 | Standard Error 49.804 | Units on a scale | |
| Change From Baseline on the CDR-CCB Power of Attention (PoA) Composite Score | 75 mg LY3154207 | -59.58 | Standard Error 54.379 | Units on a scale | |
| Change From Baseline in the 13-item Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) | Placebo | -0.71 | Standard Error 0.707 | Units on a scale | |
| Change From Baseline in the 13-item Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) | 10 mg LY3154207 | -1.11 | Standard Error 0.691 | Units on a scale | |
| Change From Baseline in the 13-item Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) | 30 mg LY3154207 | -1.42 | Standard Error 0.720 | Units on a scale | |
| Change From Baseline in the 13-item Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13) | 75 mg LY3154207 | -1.59 | Standard Error 0.799 | Units on a scale | |
| Change From Screening in the Montreal Cognitive Assessment (MoCA) Score | Placebo | 0.90 | Standard Error 0.432 | Units on a scale | |
| Change From Screening in the Montreal Cognitive Assessment (MoCA) Score | 10 mg LY3154207 | 1.34 | Standard Error 0.423 | Units on a scale | |
| Change From Screening in the Montreal Cognitive Assessment (MoCA) Score | 30 mg LY3154207 | 1.12 | Standard Error 0.448 | Units on a scale | |
| Change From Screening in the Montreal Cognitive Assessment (MoCA) Score | 75 mg LY3154207 | 1.84 | Standard Error 0.496 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03305809/results